The Once-Daily Formulation of Tacrolimus: A Step Forward in Kidney Transplantation?

被引：25
作者：
Hougardy, Jean-Michel [1 ]
de Jonge, Hylke [2 ]
Kuypers, Dirk [2 ]
Abramowicz, Daniel [1 ]
机构：
[1] Clin Univ Hop Erasme, Dept Nephrol, Renal Transplantat Clin, B-1070 Brussels, Belgium
[2] Univ Hosp Leuven, Dept Nephrol & Renal Transplantat, Louvain, Belgium
来源：
TRANSPLANTATION | 2012年 / 93卷 / 03期
关键词：
Kidney transplantation; Tacrolimus; Formulations; PROGRAF-BASED REGIMEN; TWICE-DAILY PROGRAF; EXTENDED-RELEASE FORMULATION; 2 YEARS POSTCONVERSION; RENAL-TRANSPLANTATION; CONVERSION; RECIPIENTS; ADVAGRAF; PHARMACOKINETICS; NONADHERENCE;
D O I：
10.1097/TP.0b013e31823aa56e
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Nonadherence is a critical issue in transplantation. Recently, Astellas designed a once-daily-extended release formulation of tacrolimus (Tac). Despite initial reports showing bioequivalence of Tac once-daily (Advagraf) with the original formulation requiring twice-daily intake (Tac twice-daily, Prograf), several groups have now shown a sustained decrease in Tac exposure upon conversion from Prograf to Advagraf. Here, we discuss the possible reasons for this observation and how it could affect the expected benefits of Advagraf, and we comment on the fact that a similar lack of bioequivalence might prevail with generic immunosuppressive drugs.
引用
收藏
页码：241 / 243
页数：3
相关论文
共 25 条
[1]   Comparison of generic tacrolimus and Prograf drug levels in a pediatric kidney transplant program: Brief communication [J].
Abdulnour, Husam A. ;
Araya, Carlos E. ;
Dharnidharka, Vikas R. .
PEDIATRIC TRANSPLANTATION, 2010, 14 (08) :1007-1011
[2]   Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen [J].
Alloway, R ;
Steinberg, S ;
Khalil, K ;
Gourishankar, S ;
Miller, J ;
Norman, D ;
Hariharan, S ;
Pirsch, J ;
Matas, A ;
Zaltzman, J ;
Wisemandle, K ;
Fitzsimmons, W ;
First, MR .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) :867-870
[3]   Two years postconversion from a Prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients [J].
Alloway, Rita ;
Steinberg, Steven ;
Khalil, Kassem ;
Gourishankar, Sita ;
Miller, Joshua ;
Norman, Douglas ;
Hariharan, Sundaram ;
Pirsch, John ;
Matas, Arthur ;
Zaltzman, Jeffrey ;
Wisemandle, Kathleen ;
Fitzsimmons, William ;
First, M. Roy .
TRANSPLANTATION, 2007, 83 (12) :1648-1651
[4]   Frequency and impact of nonadherence to immunosuppressants after renal transplantation: A systematic review [J].
Butler, JA ;
Roderick, P ;
Mullee, M ;
Mason, JC ;
Peveler, RC .
TRANSPLANTATION, 2004, 77 (05) :769-776
[5]   Pharmacokinetics of Once- Versus Twice-Daily Tacrolimus Formulations in Kidney Transplant Patients Receiving Expanded Criteria Deceased Donor Organs: A Single-Center, Randomized Study [J].
Cabello, M. ;
Garcia, P. ;
Gonzalez-Molina, M. ;
Diez de los Rios, M. J. ;
Garcia-Saiz, M. ;
Gutierrez, C. ;
Lopez, V. ;
Sola, E. ;
Burgos, D. ;
Hernandez, D. .
TRANSPLANTATION PROCEEDINGS, 2010, 42 (08) :3038-3040
[6]  
Canada H., 2006, BIOEQUIVALENCE REQUI
[7]   Bioequivalence testing of immunosuppressants: concepts and misconceptions [J].
Christians, Uwe ;
Klawitter, Jelena ;
Clavijo, Claudia F. .
KIDNEY INTERNATIONAL, 2010, 77 :S1-S7
[8]   A systematic review of the associations between dose regimens and medication compliance [J].
Claxton, AJ ;
Cramer, J ;
Pierce, C .
CLINICAL THERAPEUTICS, 2001, 23 (08) :1296-1310
[9]   De Novo Kidney Transplant Recipients Need Higher Doses of Advagraf Compared With Prograf to Get Therapeutic Levels [J].
Crespo, M. ;
Mir, M. ;
Marin, M. ;
Hurtado, S. ;
Estadella, C. ;
Guri, X. ;
Rap, O. ;
Moral, R. ;
Puig, J. M. ;
Lloveras, J. .
TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) :2115-2117
[10]   Tacrolimus once-daily formulation - In the prophylaxis of transplant rejection in renal or liver allograft recipients [J].
Cross, Sarah A. ;
Perry, Caroline M. .
DRUGS, 2007, 67 (13) :1931-1943
123